Last reviewed · How we verify

Actonel®

Amgen · FDA-approved active Small molecule Quality 5/100

Actonel® is a Small molecule drug developed by Amgen. It is currently FDA-approved. Also known as: Risedronate, Risedronate Sodium.

At a glance

Generic nameActonel®
Also known asRisedronate, Risedronate Sodium
SponsorAmgen
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Actonel®

What is Actonel®?

Actonel® is a Small molecule drug developed by Amgen.

Who makes Actonel®?

Actonel® is developed and marketed by Amgen (see full Amgen pipeline at /company/amgen).

Is Actonel® also known as anything else?

Actonel® is also known as Risedronate, Risedronate Sodium.

What development phase is Actonel® in?

Actonel® is FDA-approved (marketed).

Related